Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)
This study has been completed.
Study NCT00304291 Information provided by State University of New York at Buffalo
First Received: March 15, 2006 Last Updated: November 27, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neuromyelitis Optica
Myelitis, Transverse
Additional conditions recognized in this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Myelitis
Nervous System Diseases
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Cranial Nerve Diseases
Demyelinating Diseases
Eye Diseases
Immune System Diseases
Multiple Sclerosis
Neoplasms
Neoplasms by Site
Nervous System Neoplasms
Neurodegenerative Diseases
Optic Nerve Diseases
Optic Neuritis
Paraneoplastic Syndromes
Paraneoplastic Syndromes, Nervous System
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
Mitoxantrone
More general drug interventions related to this trial
Analgesics
Antineoplastic Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
State University of New York at Buffalo
EMD Serono
Back to top of Main Content
